Coronary arteritis and thrombosis caused by COVID-19-induced Multisystem Inflammatory Syndrome in an infant: first
Justine Murano1, Thibault Tromeur2, Aurélien Guédra3
1CHU Reims, Hôpital Robert Debré, Forensic Department, Reims, France; Université de Reims Champagne Ardenne, UMR-S1320 Cardiovir, Reims, France.
Insights
Multisystem inflammatory syndrome in children (MIS-C) following COVID-19 can cause severe heart issues. This case study details the first infant with confirmed arteritis, coronary dilation, and thrombosis after MIS-C.
Area of Science:
- Pediatric Cardiology
- Infectious Diseases
- Pediatric Rheumatology
Background:
- While COVID-19 often presents mildly in children, Multisystem Inflammatory Syndrome in Children (MIS-C) is a serious complication.
- MIS-C can lead to severe cardiac problems, including coronary artery abnormalities.
Abstract:
Data suggests that COVID-19 is less frequent in children, with a milder course. However, multisystem inflammatory syndrome in children has been reported to occur after COVID-19 and can cause severe cardiac manifestations, including coronary dilation and aneurysms. We report on the first histologically proven arteritis with coronary dilatation and thrombosis following Multisystem Inflammatory Syndrome induced by COVID-19 in a 21-month-old male infant.
Related Concept Videos
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Myocarditis III: Medical Management
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
